Telomir Pharmaceuticals, Inc. Accounts Payable and Accrued Liabilities
Telomir Pharmaceuticals, Inc. (TELO) had Accounts Payable and Accrued Liabilities of $478.65 thousand as of 2024-03-31, per its 10-Q filed 2024-05-13.
Discontinued › Accounts Payable and Accrued Liabilities
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent · last filed 2024-05-13
- 2024-03-31: Accounts Payable and Accrued Liabilities $478.65K.
- 2023-12-31: Accounts Payable and Accrued Liabilities $707.19K.
| Period end | Accounts Payable and Accrued Liabilities |
|---|---|
| 2024-03-31 | $478.65K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $707.19K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |